研究業績

2024年

1. Okamura M, Fujimori M, Otsuki A, Saito J, Yaguchi-Saito A, Kuchiba A, Uchitomi Y, Shimazu T. Patients' perceptions of patient-centered communication with healthcare providers and associated factors in Japan - The INFORM Study 2020.Patient Educ Couns. 2024 May;122:108170. doi: 10.1016/j.pec.2024.108170. Epub 2024 Jan 24.【PMID: 38308974】
2. Obama K, Fujimori M, Boku N, Matsuoka A, Mori K, Okizaki A, Miyaji T, Okamura M, Majima Y, Goto S, Shimazu T, Uchitomi Y. Shared decision-making support program for older patients with advanced cancer using a question prompt list and geriatric assessment: A pilot randomized controlled trial.J Geriatr Oncol. 2024 Jun;15(5):101778. doi: 10.1016/j.jgo.2024.101778. Epub 2024 May 4.【PMID:38704911 】
3. Uneno Y, Mori M, Saito J, Otsuki A, Kuchiba A, Sakurai N, Nakaya N, Fujimori M, Shimazu T; INFORM Study 2023 Group. Awareness, information sources, and beliefs regarding palliative care in the general population in Japan: a nationwide cross-sectional survey (INFORM study 2023).Jpn J Clin Oncol. 2024 Nov 2;54(11):1171-1179. doi: 10.1093/jjco/hyae092.【PMID:39033085】
4. Hasei J, Ishida H, Katayama H, Maeda N, Nagano A, Ochi M, Okamura M, Iwata S, Ikuta K, Yoshida S, Fujiwara T, Nakata E, Nakahara R, Kunisada T, Ozaki T.Utilizing the Metaverse to Provide Innovative Psychosocial Support for Pediatric, Adolescent, and Young Adult Patients with Rare Cancer.Cancers (Basel). 2024 Jul 23;16(15):2617. doi: 10.3390/cancers16152617.【PMID:39123345】
5. Li SZ, Chen SY, Chang YL, Fang CK, Fujimori M, Tang WR. Predicaments and coping strategies in implementing cancer truth-telling: a qualitative content analysis.Support Care Cancer. 2024 Aug 21;32(9):602. doi: 10.1007/s00520-024-08815-6.【PMID:39167220】
6. Akechi T, Furukawa TA, Hashimoto H, Harada Y, Ito Y, Furukawa Y, Kitano A, Maeda N, Kojima Y, Tada Y, Watanabe A, Kurata A, Matsubara T, Sakurai N, Uchitomi Y, Okamura M, Fujimori M. Smartphone-based distress screening, information provision, and psychotherapy for reducing psychological distress among AYA cancer survivors: protocol for a fully decentralized multicenter randomized controlled clinical trial.Jpn J Clin Oncol. Jpn J Clin Oncol. 2024 Dec 7;54(12):1351-1357. doi: 10.1093/jjco/hyae111.【PMID:39193645】
7. Springer F, Matsuoka A, Obama K, Mehnert-Theuerkauf A, Uchitomi Y, Fujimori M. Identifying central dimensions of quality of life including life-related values, preferences and functional health in older patients with cancer: a scoping review protocol.Front Psychol. 2024 Oct 22;15:1455825. doi: 10.3389/fpsyg.2024.1455825. eCollection 2024.【PMID:39502146】
8. Asai M, Ogawa Y, Hirayama T, Sukigara N, Yoshikawa E, Furutani S, Fujimori M, Akechi T, Suzuki S. Behavioral activation program for reducing depressive symptoms among the bereaved of cancer patients: A feasibility and preliminary effectiveness study in Japan.Palliat Support Care. 2024 Nov 7:1-9. doi: 10.1017/S1478951524001445. Online ahead of print.【PMID:39508087】
9. Kouno N, Takahashi S, Komatsu M, Sakaguchi Y, Ishiguro N, Takeda K, Fujioka K, Matsuoka A, Fujimori M, Hamamoto R. Introduction of AI Technology for Objective Physical Function Assessment.Bioengineering (Basel). 2024 Nov 16;11(11):1154. doi: 10.3390/bioengineering11111154.【PMID:39593814】

2023年

1. Hirayama T, Fujimori M, Yanai Y, Ishiki H, Shindo A, Tanaka M, Kobayashi T, Kojima R, Satomi E. Development and evaluation of the feasibility, validity, and reliability of a screening tool for determining distress and supportive care needs of adolescents and young adults with cancer in Japan.Palliat Support Care. 2023 Aug;21(4):677-687. doi: 10.1017/S147895152200092X.【PMID: 35856280】
2. Yoshida S, Shimizu K, Matsui M, Fujimori M, Uchitomi Y, Horibe K. Preferred Communication with Adolescent and Young Adult Patients Receiving Bad News About Cancer. J Adolesc Young Adult Oncol.  2023 Aug;12(4):561-568. doi: 10.1089/jayao.2022.0073. Epub 2022 Nov 11.【PMID: 36367705】
3. Okusaka T, Nakamura M, Yoshida M, Kitano M, Ito Y, Mizuno N, Hanada K, Ozaka M, Morizane C, Takeyama Y; Committee for Revision of Clinical Guidelines for Pancreatic Cancer of the Japan Pancreas Society(committee member：Fujimori M). Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis. Int J Clin Oncol. 2023 Apr;28(4):493-511. doi: 10.1007/s10147-023-02317-x. Epub 2023 Mar 15.【PMID: 36920680】
4. Okamura M, Fujimori M, Saito E, Osugi Y, Akizuki N, Uchitomi Y. Development　of an Online Communication Skills Training Program for Oncologists Working with　Adolescents and Young Adults. J Adolesc Young Adult Oncol. 2023 Jun;12(3):433-439. doi: 10.1089/jayao.2022.0102. Epub 2023 Mar 27.【PMID: 36971619】
5. Akiyama M,Ishida N,Takahashi H,Takahashi M, Otsuki A,Sato Y, Saito J,Yaguchi-Saito A, Fujimori M,Kaji Y,Shimazu T; INFORM Study Group.Screening practices of cancer survivors and individuals whose family or friends had a cancer diagnoses-a nationally representative cross-sectional survey in Japan (INFORM Study 2020).J Cancer Surviv. 2023 Jun;17(3):663-676. doi: 10.1007/s11764-023-01367-4. Epub 2023 Apr 12.【PMID:37041402】
6. Yamada Y,Fujiwara M,Etoh T, Wada R,Inoue S,Mimaki Y,Kodama M,Yoshimura Y,Horii S,Matsushita T,Fujimori M,Shimazu T,Nakaya N,Hinotsu S,Tabata M,Tamura K,Uchitomi Y,Yamada N,Nagoshi K, Inagaki M.Perceptions toward issues in cancer care for people with mental illness among psychiatric care providers: A questionnaire study.Psychooncology. 2023 Jul;32(7):1022-1029. DOI: 10.1002/pon.6143.Epub 2023 Apr 23.【PMID:37089028】
7. Ogata D ,Namikawa K,Nakano E,Fujimori M,Uchitomi Y, Higashi T,Yamazaki N,Kawai A. Epidemiology of skin cancer based on Japan's National Cancer Registry 2016-2017. Cancer Sci. 2023 Jul;114(7):2986-2992. DOI: 10.1111/cas.15823.Epub 2023 Apr 24.【PMID:37095610】
8. Uchida M, Furukawa TA, Yamaguchi T, Imai F, Momino K, Katsuki F, Sakurai N, Miyaji T, Horikoshi M, Iwata H, Zenda S, Iwatani T, Ogawa A, Inoue A, Abe M, Toyama T, Uchitomi Y, Matsuoka H, Noma H, Akechi T.Optimization of smartphone psychotherapy for depression and anxiety among patients with cancer using the multiphase optimization strategy (MOST) framework and decentralized clinical trial system (SMartphone Intervention to LEssen depression/Anxiety and GAIN resilience: SMILE AGAIN project): a protocol for a randomized controlled trial.Trials. 2023 May 22;24(1):344. doi: 10.1186/s13063-023-07307-y.【PMID:37217965】
9. Ishikawa H,Ogawa R,Otsuki A,Saito J, Yaguchi-Saito A, Kuchiba A,Fujimori M, Fukuda Y,Shimazu T; INFORM Study Group.Effect modification by geographic area on the association between health literacy and self-rated health: a nationwide cross-sectional study in Japan.BMC Public Health. 2023 May 25;23(1):952. DOI: 10.1186/s12889-023-15897-0.【PMID:37231363】
10. Nishino M, Fujimori M, Koyama T, Hirata M, Tanabe N, Shimizu T, Yamamoto N, Uchitomi Y. Prevalence of psychological distress, quality of life, and satisfaction among patients and family members following comprehensive genomic profiling testing: Protocol of the Quality of life for Cancer genomics and Advanced Therapeutics (Q-CAT) study.PLoS One. 2023 May 26;18(5):e0283968. DOI: 10.1371/journal.pone.0283968.eCollection 2023.【PMID:37235572】
11. Saito J,Odawara M,Fujimori M,Kuchiba A,Oyamada S, Khin Thet Swe,Saito E,Fukai K,Tatemichi M,Nakamura M,Uchitomi Y,Shimazu T .Interactive assistance via eHealth for small- and medium-sized enterprises' employer and health care manager teams on tobacco control (eSMART-TC): protocol for a cluster randomized hybrid type II trial (N-EQUITY2101/J-SUPPORT2102).Implement Sci Commun. 2023 Jun 7;4(1):61. DOI: 10.1186/s43058-023-00444-0.【PMID:37287041】
12. Sadahiro R, Hatta K, Yamaguchi T, Masanori E, Matsuda Y, Ogawa A, Iwata Y, Tokoro A, Nakahara R, Hirayama T, Yanai Y, Ogawa Y, Kayano A, Ariyoshi K, Oyamada S, Uchitomi Y, Akechi T, Yamamoto N, Okita N, Yorikane E, Shimada K, Furukawa T, Hashimoto H, Maeda M, Sato T, Sekimoto A, Sasaki C, Saito E, Uezono Y, Matsuoka H. A multi-centre, double-blind, randomized, placebo-controlled trial to evaluate the effectiveness and safety of ramelteon for the prevention of postoperative delirium in elderly cancer patients: a study protocol for JORTC-PON2/J-SUPPORT2103/NCCH2103.Jpn J Clin Oncol. 2023 Aug 30;53(9):851-857. doi: 10.1093/jjco/hyad061.【PMID:37340766】
13. Mori M, Cheng-Pei Lin, Shao-Yi Cheng, Sang-Yeon Suh, Takenouchi S, Raymond Ng, Helen Chan, Sun-Hyun Kim, Ping-Jen Chen, Kwok Keung Yuen,Fujimori M,Yamaguchi T,Hamano J,Kizawa Y,MoritaT, Diah Martina.Communication in Cancer Care in Asia: A Narrative Review. JCO Glob Oncol. 2023 Jun:9:e2200266.  DOI: 10.1200/GO.22.00266.【PMID:37364221】
14. Kamo Y, Fujimori M, Asai M, Oishi T, Mori M, Miyashita M, Morita T, Uchitomi Y. Validity and reliability of the Japanese version of the Patient Satisfaction Questionnaire (PSQ-J) for evaluating oncologist consultations.PEC Innov. 2023 May 18:2:100166. doi: 10.1016/j.pecinn.2023.100166. eCollection 2023 Dec.【PMID:37384155】
15. Fujiwara M, Yamada Y,Shimazu T,Nakaya N,Hinotsu S,Fujimori M,Uchitomi Y,Inagaki M. Increasing disparities in cancer screening among people with severe mental illness during the COVID-19 pandemic.Schizophr Res. 2023 Aug:258:18-20. doi: 10.1016/j.schres.2023.07.006. Epub 2023 Jul 14.【PMID:37454524】
16. Asai M,Fujimori M, Kamo Y, Marij A Hillen , Oishi T, Miyashita M, Mori M, Morita T, Uchitomi Y.Validation of the Japanese version of the full and short form Trust in Oncologist Scale. Palliat Support Care. 2023 Jul 25:1-8.DOI: 10.1017/S1478951523000937.Online ahead of print.【PMID:37489279】
17. Itani Y, Obama K, Fujimori M, Saito J, Uchitomi Y.Cancer treatment-related financial toxicity in Japan: a scoping review. Front Psychol. 2023 Aug 1:14:1205016.DOI: 10.3389/fpsyg.2023.1205016.【PMID:37593650】
18. Matsuoka A, Mizutani T, Kaji Y, Yaguchi-Saito A, Odawara M, Saito J, Fujimori M, Uchitomi Y, Shimazu T. Barriers and facilitators to implementing geriatric assessment in daily oncology practice in Japan: A qualitative study using an impleentation framework.J Geriatr Oncol. 2023 Nov;14(8):101625. doi: 10.1016/j.jgo.2023.101625. Epub 2023 Sep 13.【PMID:37708801】
19. Kurisu K, Harashima S, Fujimori M, Akechi T, Yoshiuchi K, Uchitomi Y. Regional disparities in suicide among patients with cancer: A nationwide population-based study in Japan.Cancer Med. 2023 Oct;12(19):20052-20058. doi: 10.1002/cam4.6574. Epub 2023 Sep 22.【PMID:37737044】
20. Mori M, Lin CP, Cheng SY, Suh SY, Takenouchi S, Ng R, Chan H, Kim SH, Chen PJ, Yuen KK, Fujimori M, Yamaguchi T, Hamano J, Kizawa Y, Morita T, Martina D.Reply to R.V. Patel et al.JCO Glob Oncol. 2023 Sep;9:e2300293. doi: 10.1200/GO.23.00293.【PMID:37856772】
21. Terada M, Shimazu T, Saito J, Odawara M, Otsuki A, Yaguchi-Saito A, Miyawaki R, Kuchiba A, Ishikawa H, Fujimori M, Kreps GL; INFORM Study Group. Age, gender and socioeconomic disparities in human papillomavirus (HPV) awareness and knowledge among Japanese adults after a 7-year suspension of proactive recommendation for the HPV vaccine: A nationally representative cross-sectional survey.Vaccine. 2023 Nov 22;41(48):7147-7158. doi: 10.1016/j.vaccine.2023.10.024. Epub 2023 Oct 20.【PMID:37866996】
22. Matsuoka A, Fujimori M, Koyama T, Sato A, Mori K, Hirata M, Tanabe N, Nakachi K, Kato S, Okamoto H, Ogawa K, Komatsu H, Iwasaku M, Miyaji T, Uchitomi Y. Prevalence of psychological distress and associated factors among patients undergoing comprehensive genomic profiling testing: protocol for a multicentre, prospective, observational study.BMJ Open. 2023 Nov 23;13(11):e072472. doi: 10.1136/bmjopen-2023-072472.【PMID:37996226】
23. Miyawaki R, Oka K, Otsuki A, Saito J, Yaguchi-Saito A, Kuchiba A, Fujimori M, Kreps GL, Shimazu T; INFORM Study Group.Trust in Mass Media as Sources of Cancer Information: Findings from a Nationally Representative Cross-Sectional Survey in Japan.J Health Commun. 2024 Feb;29(2):143-154. doi: 10.1080/10810730.2023.2294471. Epub 2024 Jan 17.【PMID:38126891】
24. Fujiwara M, Yamada Y, Etoh T, Shimazu T, Kodama M, Yamada N, Asada T, Horii S, Kobayashi T, Hayashi T, Ehara Y, Fukuda K, Harada K, Fujimori M, Odawara M, Takahashi H, Hinotsu S, Nakaya N, Uchitomi Y, Inagaki M.A feasibility study of provider-level implementation strategies to improve access to colorectal cancer screening for patients with schizophrenia: ACCESS2 (N-EQUITY 2104) trial.Implement Sci Commun. 2024 Jan 4;5(1):2. doi: 10.1186/s43058-023-00541-0.【PMID:38178209】
25. Momosaka T, Saito J, Otsuki A, Yaguchi-Saito A, Fujimori M, Kuchiba A, Katanoda K, Takaku R, Shimazu T.Associations of individual characteristics and socioeconomic status with heated tobacco product harmfulness perceptions in Japan: A nationwide cross-sectional study (INFORM Study 2020).J Epidemiol. 2024 Sep 5;34(9):411-418. doi: 10.2188/jea.JE20230177. Epub 2024 Jul 31.【PMID:38191179】
26. Grassi L, Watson M,IPOS Federation of Psycho-Oncology Societies'. Core-curriculum in psycho-oncology: Towards the certification of the psycho-oncologist profession. Psychooncology. 2024 Jan;33(1):e6285. doi:10.1002/pon.6285.【PMID:38282216】
27. Goto S, Itani Y, Fujimori M, Okamura M, Obama K, Sato A, Uchitomi Y. Impact of work-related changes on health-related quality of life in adolescent and young adult cancer survivors. Journal of Psychosocial Oncology Research and Practice. 2024:6:1.
28. Akechi T, Furukawa TA, Noma H, Iwata H, Toyama T, Higaki K, Matsuoka H, Zenda S, Iwatani T, Akahane K, Inoue A, Sagara Y, Uchida M, Imai F, Momino K, Imaizumi G, Yamaguchi T, Mashiko T, Miyaji T, Horikoshi M, Sakurai N, Onishi T, Kanemitsu Y, Murata T, Wanifuchi-Endo Y, Kuroda H, Nishikawa R, Miyashita M, Abe M, Uchitomi Y; J-SUPPORT 2001 Study group. Optimizing smartphone psychotherapy for depressive symptoms in patients with cancer: Multiphase optimization strategy using a decentralized multicenter randomized clinical trial (J-SUPPORT 2001 Study).Psychiatry Clin Neurosci.2024 Jun;78(6):353-361. doi: 10.1111/pcn.13657. Epub 2024 Mar 11.【PMID:38468404】

2022年

1. Matsumoto Y, Umemura S, Okizaki A, Fujisawa D, Kobayashi N, Tanaka Y, Sasaki C, Shimizu K, Ogawa A, Kinoshita H, Uchitomi Y, Yoshiuchi K, Matsuyama Y, Morita T, Goto K, Ohe Y. Early specialized palliative care for patients with metastatic lung cancer receiving chemotherapy: a feasibility study of a nurse-led screening-triggered programme. Jpn J Clin Oncol. 2022 Apr 6;52(4):375-382. [PMID:35079813]
2. Sato A, Fujimori M, Shirai Y, Umezawa S, Mori M, Jinno S, Umehashi M, Okamura M, Okusaka T, Majima Y, Miyake S, Uchitomi Y. Assessing the need for a question prompt list that encourages end-of-life discussions between patients with advanced cancer and their physicians: A focus group interview study - ERRATUM. Palliat Support Care. 2022 Aug;20(4):618-620.doi: 10.1017/S1478951522000153.[PMID:35135645]
3. Matsuoka A, Fujimori M. Interpretation of the Efficacy of Multidisciplinary Geriatric Assessment Intervention on Chemotherapy-Related Toxic Effects in Older Adults With Cancer. JAMA Oncol. 2022 Apr 1;8(4):1. [PMID:35201282]
4. Okamura M, Fujimori M, Goto S, Obama K, Kadowaki M, Sato A, Hirayama T, Uchitomi Y. Prevalence and associated factors of psychological distress among young adult cancer patients in Japan. Palliat Support Care. 2023 Feb;21(1):93-99.doi: 10.1017/S1478951521002054. [PMID:35225198]
5. Akechi T, Kubota Y, Ohtake Y, Setou N, Fujimori M, Takeuchi E, Kurata A, Okamura M, Hasuo H, Sakamoto R, Miyamoto S, Asai M, Shinozaki K, Onishi H, Shinomiya T, Okuyama T, Sakaguchi Y, Matsuoka H. Clinical practice guidelines for the care of psychologically distressed bereaved families who have lost members to physical illness including cancer. Jpn J Clin Oncol. 2022 Mar 6:hyac025. [PMID:35253040]
6. Kurisu K, Hashimoto M, Ishizawa T, Shibayama O, Inada S, Fujisawa D, Inoguchi　H, Shimoda H, Inoue S, Ogawa A, Akechi T, Shimizu K, Uchitomi Y, Matsuyama Y,　Yoshiuchi K. Development of computer adaptive testing for measuring depression　in patients with cancer. Sci Rep. 2022 May 17;12(1):8247. [PMID:35581321]
7. Yaguchi-Saito A, Kaji Y, Matsuoka A, Okuyama A, Fujimori M, Saito J, Odawara M, Otsuki A, Uchitomi Y, Zenda S, Shimazu T. Factors affecting the implementation of guideline-based prophylactic antiemetic therapy for chemotherapy-induced nausea and vomiting in Japan: a protocol for a hospital-based qualitative study. BMJ open. 2022;12(6):e055473.【PMID: 35667723】
8. Yokota T, Ueno T, Soga Y, Ishiki H, Uezono Y, Mori T, Zenda S, Uchitomi Y. J-SUPPORT research policy for oral mucositis associated with cancer treatment. Cancer medicine. 2022;11(24):4816-29.【PMID: 35691025】
9. Yamada Y, Fujiwara M, Shimazu T, Etoh T, Kodama M, So R, Matsushita T, Yoshimura Y, Horii S, Fujimori M, Takahashi H, Nakaya N, Miyaji T, Hinotsu S, Harada K, Okada H, Uchitomi Y, Yamada N, Inagaki M. Patients' acceptability and implementation outcomes of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia: a qualitative secondary analysis of a mixed-method randomised clinical trial. BMJ open. 2022;12(6):e060621.【PMID: 35701062】
10. Yamada Y, Fujiwara M, Etoh T, Wada R, Inoue S, Kodama M, Yoshimura Y, Horii S, Matsushita T, Fujimori M, Shimazu T, Nakaya N, Hinotsu S, Tabata M, Tamura K, Uchitomi Y, Yamada N, Inagaki M. Issues of cancer care in people with mental disorders as perceived by cancer care providers: A quantitative questionnaire survey. Psycho-oncology. 2022;31(9):1572-80.【PMID: 35770322】
11. Sato A, Fujimori M, Shirai Y, Umezawa S, Mori M, Jinno S, Umehashi M, Okamura M, Okusaka T, Majima Y, Miyake S, Uchitomi Y. Assessing the need for a question prompt list that encourages end-of-life discussions between patients with advanced cancer and their physicians: A focus group interview study. Palliative & supportive care. 2022;20(4):564-9.【PMID: 35876449】
12. Sadahiro R, Wada S, Matsuoka YJ, Uchitomi Y, Yamaguchi T, Sato T, Esaki M, Yoshimoto S, Daiko H, Kanemitsu Y, Kawai A, Kato T, Fujimoto H, Uezono Y, Shimizu K, Matsuoka H. Prevention of delirium with agitation by yokukansan in older adults after cancer surgery. Japanese journal of clinical oncology. 2022;52(11):1276-81.【PMID: 35907781】
13. Kurisu K, Fujimori M, Harashima S, Akechi T, Matsuda T, Saika K, Yoshiuchi K, Miyashiro I, Uchitomi Y. Suicide, other externally caused injuries, and cardiovascular disease within 2 years after cancer diagnosis: A nationwide population-based study in Japan (J-SUPPORT 1902). Cancer medicine. 2023;12(3):3442-51.【PMID: 35941747】
14. Maeda O, Matsuoka A, Yanagawa M, Muroyama Y, Watanabe K, Liang Y, Ishikawa T, Ohno E, Kawashima H, Umegaki H, Kuzuya M, Ando Y. Selection of chemotherapy for older patients with pancreatic cancer based on geriatric assessment. Journal of geriatric oncology. 2022;13(8):1260-3.【PMID: 36115797】
15. Fang JT, Chen SY, Yang LY, Liao KC, Lin CH, Fujimori M, Tang WR. Improving transitional care through online communication skills training. Aging clinical and experimental research. 2022;34(12):3063-71.【PMID: 36129617】
16. Matsuoka A, Fujimori M, Narikazu B, Takashima A, Okusaka T, Mori K, Akechi T, Shimazu T, Okizaki A, Miyaji T, Majima Y, Nagashima F, Uchitomi Y. Geriatric assessment and management with question prompt list using a web-based application for elderly patients with cancer (MAPLE) to communicate ageing-related concerns: J-SUPPORT 2101 study protocol for a multicentre, parallel group, randomised controlled trial. BMJ open. 2022;12(9):e063445.【PMID: 36167377】
17. Akechi T, Yamaguchi T, Uchida M, Imai F, Momino K, Katsuki F, Sakurai N, Miyaji T, Mashiko T, Horikoshi M, Furukawa TA, Yoshimura A, Ohno S, Uehiro N, Higaki K, Hasegawa Y, Akahane K, Uchitomi Y, Iwata H. Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2023;41(5):1069-78.【PMID: 36322882】
18. Odawara M, Saito J, Yaguchi-Saito A, Fujimori M, Uchitomi Y, Shimazu T. Using implementation mapping to develop strategies for preventing non-communicable diseases in Japanese small- and medium-sized enterprises. Frontiers in public health. 2022;10:873769.【PMID: 36276371】
19. Matsuoka A, Shimazu T, Takahashi M, Nagashima F, Nishiyama H, Fujimori M, Ando Y. A nationwide, cross-sectional, web-based survey on healthcare providers' knowledge about, attitudes toward, and perceived barriers to adherence to clinical practice guidelines for anticancer drug therapy for older patients with cancer in Japan. J Geriatr Oncol. 2023 Jan;14(1):101399. 【PMID: 36357276】
20. Zenda S, Arai Y, Sugawara S, Inaba Y, Hashimoto K, Yamamoto K, Saigusa Y, Kawaguchi T, Shimada S, Yokoyama M, Miyaji T, Okano T, Nakamura N, Kobayashi E, Takagi T, Matsumoto Y, Uchitomi Y, Sone M. Protocol for a confirmatory trial of the effectiveness and safety of palliative arterial embolization for painful bone metastases. BMC cancer. 2023;23(1):109.【PMID: 36721103】
21. Hirayama T, Fujimori M, Ito Y, Ishida Y, Tsumura A, Ozawa M, Maeda N, Yamamoto K, Takita S, Mori M, Tanaka K, Horibe K, Akechi T. Feasibility and preliminary effectiveness of a psychosocial support program for adolescent and young adult cancer patients in clinical practice: a retrospective observational study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2023;31(2):146.【PMID: 36729199】
22. Okamura M, Fujimori M, Goto S, Ohisa K, Boku N, Nakahara R, Uchitomi Y, Suzuki T, Matsuda T. Psychological distress among healthcare providers in oncology during the COVID-19 pandemic in Japan: The mediating role of moral distress and resilience.Front Psychol. 2023 Feb 1;14:11:05800. doi: 10.3389/fpsyg.2023.1105800. eCollection 2023.【PMID: 36818071】
23. Mitsutake S, Takahashi Y, Otsuki A, Umezawa J, Yaguchi-Saito A, Saito J, Fujimori M, Shimazu T. Chronic Diseases and Sociodemographic Characteristics Associated With Online Health Information Seeking and Using Social Networking Sites: Nationally Representative Cross-sectional Survey in Japan. Jounal of medical Internet research. 2023;25:e44741.【PMID: 36862482】
24. Obama K, Fujimori M, Okamura M, Kadowaki M, Ueno T, Boku N, Mori M, Akechi T, Yamaguchi T, Oyamada S, Okizaki A, Miyaji T, Sakurai N, Uchitomi Y. Effectiveness of a facilitation programme using a mobile application for initiating advance care planning discussions between patients with advanced cancer and healthcare providers: protocol for a randomised controlled trial (J-SUPPORT 2104). BMJ Open. 2023 Mar 28;13(3):e069557.【PMID: 36977536】

2021年

1. Etoh T, Fujiwara M, Yamada Y, Wada R, Higuchi Y, Inoue S, Kodama M, Matsushita T, Yoshimura Y, Horii S, Fujimori M, Kakeda K, Shimazu T, Nakaya N, Tabata M, Uchitomi Y, Yamada N, Inagaki M. Cancer care for people with mental disorders: A qualitative survey among cancer care and psychiatric care professionals in Japan. Psychooncology. 2021 Dec;30(12):2060-2066. [34435715]
2. Inoue K, Kawashima Y, Noguchi H, Fujimori M, Akechi T, Kawanishi C, Uchitomi Y, Matsuoka YJ*. Attitude to suicide prevention and suicide intervention skills among oncology professionals: An online cross-sectional survey in Japan. Psychiatry Clin Neurosci. 2021 Dec;75(12):401-402. [34435416]
3. Fujiwara M, Yamada Y, Shimazu T, Kodama M, So R, Matsushita T, Yoshimura Y, Horii S, Fujimori M, Takahashi H, Nakaya N, Kakeda K, Miyaji T, Hinotsu S, Harada K, Okada H, Uchitomi Y, Yamada N, Inagaki M. Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial. Acta Psychiatr Scand. 2021 Jul 9. [34242396]
4. Okamura M, Fujimori M*, Hata K, Mori M, Mack JW, Prigerson HG, Uchitomi Y. Validity and reliability of the Japanese version of the Peace, Equanimity, and Acceptance in the Cancer Experience (PEACE) questionnaire. Palliat Support Care. 2022 Aug;20(4):549-555. [34190680]
5. Wada R, Fujiwara M, Yamada Y, Nakaya N, Fujimori M, So R, Kodama M, Higuchi Y, Kakeda K, Uchitomi Y, Yamada N, Inagaki M. Validity and Reliability of the Japanese Version of the 12-item Self-administered World Health Organization Disability Assessment Schedule (WHODAS) 2.0 in Patients with Schizophrenia. Acta Med Okayama. 2021 Jun;75(3):315-322 .[34176935]
6. Wu Y, Levis B, Sun Y, He C, Krishnan A, Neupane D, Bhandari PM, Negeri Z, Benedetti A, Thombs BD; DEPRESsion Screening Data (DEPRESSD) HADS Group. Accuracy of the Hospital Anxiety and Depression Scale Depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis. BMJ. 2021 May 10;373:n972. [33972268]
7. Harashima S, Fujimori M*, Akechi T, Matsuda T, Saika K, Hasegawa T, Inoue K, Yoshiuchi K, Miyashiro I, Uchitomi Y, Matsuoka YJ. Death by suicide, other externally caused injuries and cardiovascular diseases within 6 months of cancer diagnosis (J-SUPPORT 1902). Jpn J Clin Oncol 2021 Feb 3;hyab001 [33529336]
8. Chen SH, Chen SY, Yang SC, Chien RN, Chen SH, Chu TP, Fujimori M, Tang WR. Effectiveness of communication skill training on cancer truth-telling for advanced practice nurses in Taiwan: A pilot study. Psychooncology. 2021 May;30(5):765-772. doi: 10.1002/pon.5629. Epub 2021 Jan 25. [33427382]
9. Okamura M, Fujimori M*, Sato A, Uchitomi Y. Unmet supportive care needs and associated factors among young adult cancer patients in Japan. BMC Cancer. 2021 Jan 5;21(1):17. doi: 10.1186/s12885-020-07721-4. [33402126]
10. Brehaut E, Neupane D, Levis B, Wu Y, Sun Y, Krishnan A, He C, Bhandari PM, Negeri Z, Riehm KE, Rice DB, Azar M, Yan XW, Imran M, Chiovitti MJ, Saadat N, Cuijpers P, Ioannidis JPA, Markham S, Patten SB, Ziegelstein RC, Henry M, Ismail Z, Loiselle CG, Mitchell ND, Tonelli M, Boruff JT, Kloda LA, Beraldi A, Braeken APBM, Carter G, Clover K, Conroy RM, Cukor D, da Rocha E Silva CE, De Souza J, Downing MG, Feinstein A, Ferentinos PP, Fischer FH, Flint AJ, Fujimori M, Gallagher P, Goebel S, Jetté N, Julião M, Keller M, Kjærgaard M, Love AW, Löwe B, Martin-Santos R, Michopoulos I, Navines R, O'Rourke SJ, Öztürk A, Pintor L, Ponsford JL, Rooney AG, Sánchez-González R, Schwarzbold ML, Sharpe M, Simard S, Singer S, Stone J, Tung KY, Turner A, Walker J, Walterfang M, White J, Benedetti A, Thombs BD. Depression prevalence using the HADS-D compared to SCID major depression classification: An individual participant data meta-analysis. J Psychosom Res. 2020 Dec;139:110256. [33069051]
11. Fujimori M*, Sato A, Jinno S, Okusaka T, Yamaguchi T, Ikeda M, Ueno M, Ozaka M, Takayama Y, Miyaji T, Majima Y, Uchitomi Y. Integrated communication support program for oncologists, caregivers and patients with rapidly progressing advanced cancer to promote patient-centered communication: J-SUPPORT 1904 study protocol for a randomised controlled trial. BMJ Open. 2020 Sep 23;10(9):e036745. [32967874]
12. Wu Y, Levis B, Ioannidis JPA, Benedetti A, Thombs BD; DEPRESsion Screening Data (DEPRESSD) Collaboration. Probability of Major Depression Classification Based on the SCID, CIDI, and MINI Diagnostic Interviews: A Synthesis of Three Individual Participant Data Meta-Analyses. Psychother Psychosom. 2021;90(1):28-40. [32814337]
13. Wada S, Matsuoka YJ, Uchitomi Y, Yamaguchi T, Sato T, Shimada K, Yoshimoto S, Daiko H, Kanemitsu Y, Kawai A, Kato T, Fujimoto H, Shimizu K*: Yokukansan for treatment of preoperative anxiety and prevention of postoperative delirium in cancer patients undergoing highly invasive surgery. J-SUPPORT 1605 (ProD Study): A randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage 2021 Jan;61(1):71-80. [32800969]
14. Saito J, Odawara M, Takahashi H, Fujimori M, Yaguchi-Saito A, Inoue M, Uchitomi Y, Shimazu T*. Barriers and facilitative factors in the implementation of workplace health promotion activities in small and medium-sized enterprises: a qualitative study. Implement Sci Commun. 2022 Mar 2;3(1):23. [35236511]

2020年

1. Fujisawa D, Umezawa S, Fujimori M, Miyashita M. Prevalence and associated factors of perceived cancer-related stigma in Japanese cancer survivors. Jpn J Clin Oncol. 2020 Oct 22;50(11):1325-1329. [32776092]
2. Chen SY, Fujimori M, Wang HM, Tang WR. Gender Differences in Cancer Patients' Preferences for Truth-Telling in Taiwan. Cancer Nurs. 2020 Jul 8. [32649335]
3. Higuchi Y, Fujiwara M, Nakaya N, Fujimori M, Yamada Y, Wada R, Etoh T, Kakeda K, Uchitomi Y, Yamada N, Inagaki M. Trends in smoking rates among individuals with serious psychological distress: Analysis of data from a Japanese national survey, 2007-2016. Psychiatry Res. 2020 Sep;291:113225. [32599444]
4. Fuijmori M*, Harashima S. Risk of suicide among adolescents and young adults with cancer and a need for targeted interventions. Ann Transl Med 2020 Apr;8(7):428 [32395472]
5. Wu Y, Levis B, Sun Y, Krishnan A, He C, Riehm KE, Rice DB, Azar M, Yan XW, Neupane D, Bhandari PM, Imran M, Chiovitti MJ, Saadat N, Boruff JT, Cuijpers P, Gilbody S, McMillan D, Ioannidis JPA, Kloda LA, Patten SB, Shrier I, Ziegelstein RC, Henry M, Ismail Z, Loiselle CG, Mitchell ND, Tonelli M, Al-Adawi S, Beraldi A, Braeken APBM, Büel-Drabe N, Bunevicius A, Carter G, Chen CK, Cheung G, Clover K, Conroy RM, Cukor D, da Rocha E Silva CE, Dabscheck E, Daray FM, Douven E, Downing MG, Feinstein A, Ferentinos PP, Fischer FH, Flint AJ, Fujimori M, Gallagher P, Gandy M, Goebel S, Grassi L, Härter M, Jenewein J, Jetté N, Julião M, Kim JM, Kim SW, Kjærgaard M, Köhler S, Loosman WL, Löwe B, Martin-Santos R, Massardo L, Matsuoka Y, Mehnert A, Michopoulos I, Misery L, Navines R, O'Donnell ML, Öztürk A, Peceliuniene J, Pintor L, Ponsford JL, Quinn TJ, Reme SE, Reuter K, Rooney AG, Sánchez-González R, Schwarzbold ML, Senturk Cankorur V, Shaaban J, Sharpe L, Sharpe M, Simard S, Singer S, Stafford L, Stone J, Sultan S, Teixeira AL, Tiringer I, Turner A, Walker J, Walterfang M, Wang LJ, White J, Wong DK, Benedetti A, Thombs BD. Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale - Depression subscale scores: An individual participant data meta-analysis of 73 primary studies. J Psychosom Res. 2020 Feb;129:109892. [31911325]
6. Wada S, Sadahiro R, Matsuoka Y, Uchitomi Y, Shimizu K*. The association between postoperative recovery and psychosocial factors in cancer patients. J Surgery 2020;8(1):9-15 [10.11648/j.js.20200801.13]

2019年

1. Fujiwara M, Inagaki M*, Shimazu T, Kodama M, So R, Matsushita T, Yoshimura Y, Horii S, Fujimori M, Takahashi H, Nakaya N, Kakeda K, Miyaji T, Hinotsu S, Harada K, Okada H, Uchitomi Y, Yamada N. A randomised controlled trial of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia in psychiatric outpatient clinics: study protocol for the J-SUPPORT 1901 (ACCESS) study. BMJ Open 2019 Nov 2;9(11):e03295 [31678957]
2. Higuchi Y, Fujiwara M, Nakaya N, U, Hayashibara C, So R, Shinkawa I, Sato K, Yada Y, Kodama M, Takenaka H, Kishi Y, Kakeda K, Uchitomi Y, Yamada N, Inagaki M. Change in smoking cessation stage over 1 year in patients with schizophrenia: a follow up study in Japan.　BMC Psychiatry. 2019 Nov 21;19(1):367. [31752799]
3. Mori M*, Fujimori M*, van Vliet LM, Yamaguchi T, Shimizu C, Kinoshita T, Morishita-Kawahara M, Inoue A, Inoguchi H, Matsuoka Y, Bensing JM, Bruera E, Morita T, Uchitomi Y. Explicit prognostic disclosure to Asian women with breast cancer: a randomized script video-vignette study (J-SUPPORT1601). Cancer 2019 Oct 1;125(19):3320-3329. [31206639]
4. Sadahiro R, Sawada N*, Matsuoka YJ*, Mimura M, Nozaki S, Ryo S, Goto A, Tsugane S. Midlife cancer/diabetes and risk of dementia and MCI: a population-based prospective cohort study in Japan. Psychiatry Clin Neurosci 2019 Sep;73(9):597-599. [31226234]
5. Mori M*, Fujimori M, Ishiki H, Nishi T, Hamano J, Otani H, Uneno Y, Oba A, Morita T, Uchitomi Y. Adding a Wider Range and "Hope for the Best, and Prepare for the Worst" Statement: Preferences of Patients with Cancer for Prognostic Communication. Oncologist. 2019 Sep;24(9):e943-e952. [30782978]
6. Harashima S, Fujimori M*, Akechi T, Matsuda T, Saika K, Hasegawa T, Inoue K, Yoshiuchi K, Miyashiro I, Uchitomi Y, Matsuoka YJ. Suicide, other externally caused injuries, and cardiovascular death following a cancer diagnosis: study protocol for a nationwide population-based study in Japan. BMJ Open 2019 Jul 4;9(7):e030681 [31278108]
7. Mori M*, Fujimori M, Ishiki H, Nishi T, Hamano J, Otani H, Uneno Y, Oba A, Morita T, Uchitomi Y：The effects of adding reassurance statements: Cancer patients' preferences for phrases in end-of-life discussions. J Pain Symptom Manage 2019 Jun;57(6):1121-1129. [30818028]
8. Wada S, Sadahiro R, Matsuoka YJ, Uchitomi Y, Yamaguchi T, Shimizu K*: Yokukansan for perioperative psychiatric symptoms in cancer patients undergoing high invasive surgery: a randomized, double-blind, placebo-controlled trial. J-SUPPORT1605 (ProD Study). Trials 2019 Feb 8;20(1): 110 [30736826]
9. Wada S, Sadahiro R, Inoguchi H, Sadahiro R, Matsuoka YJ, Uchitomi Y, Sato T, Shimada K, Yoshimoto S, Daiko H, Shimizu K*. Preoperative anxiety as a predictor of delirium in cancer patients: a prospective observational cohort study. World J Surgery 2019 Jan;43(1): 134-142 [30128769]
10. Shibayama O, Yoshiuchi K, Inagaki M, Matsuoka Y, Yoshikawa E, Sugawara Y, Akechi T, Wada N, Imoto S, Murakami K, Ogawa A, Uchitomi Y*: Longterm influence of adjuvant breast radiotherapy on cognitive function in breast cancer patients treated with conservation therapy. Int J Clin Oncol 2019 Jan; 24(1): 68-77. [30168090]

2018年

1. Yamada Y, Fujimori M*, Shirai Y, Ninomiya H, Oka T, Uchitomi Y: Changes in Physicians' Intrapersonal Empathy After a Communication Skills Training in Japan. Acad Med. 2018 Dec;93(12):1821-1826 [30134272]
2. Tagami K, Okizaki A, Miura T, Watanabe YS, Matsumoto Y, Morita T, Fujimori M, Kinoshita H. Breakthrough Cancer Pain Influences General Activities and Pain Management: A Comparison of Patients with and without Breakthrough Cancer Pain. J Palliat Med. 2018 Nov;21(11):1636-1640.[29975582]
3. Hashimoto H, Abe M, Yanai T, Yamaguchi T, Zenda S, Uchitomi Y, Fukuda H, Mori M, Iwasa S, Yamamoto N, Ohe Y. Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy. Jpn J Clin Oncol. 2018 Oct 1;48(10):950-952. [30124989]
4. Zenda S*, Yamaguchi T, Yokota T, Miyaji T, Mashiko T, Tanaka M, Yonemura M, Takeno M, Okano T, Kawasaki T, Nakamori Y, Ishii S, Shimada S, Uchitomi Y. Topical Steroid versus Placebo for the Prevention of Radiation Dermatitis in Head and Neck Cancer Patients receiving Chemoradiotherapy: The Study Protocol of J-SUPPORT 1602 (TOPICS Study), a Randomized Double-blinded Phase 3 Trial. BMC Cancer. 2018 Sep 6;18(1):873. [30189840]
5. Fujiwara M, Inagaki M*, Nakaya N, Fujimori M, Higuchi Y, Kakeda K, Uchitomi Y, Yamada N.: Smoking among adults with serious psychological distress: analysis of anonymized data from a national cross-sectional survey in Japan. J Affective Disorders 2018 Jul 3;239:131-137 [30005326]
6. Watanabe Y, Miura T, Okizaki A, Tagami K, Matsumoto Y, Fujimori M, Morita M, Kinoshita H: Comparison of indicators for achievement of pain control with personalized pain goal in a comprehensive cancer center. J Pain Symptom Manage. 2018 Apr;55(4):1159-1164. [29248568]
7. Inagaki M*, Fujiwara M, Nakaya N, Fujimori M, Higuchi Y, Hayashibara C, So R, Kakeda K, Kodama M, Uchitomi Y, Yamada N: Low Cancer Screening Rates among Japanese People with Schizophrenia: A Cross-Sectional Study. Tohoku J Experiment Med, 2018 Mar; 244(3): 209-218 [29540627]
8. Fujiwara M, Inagaki M, Nakaya N, Fujimori M, Higuchi Y, Kakeda K, Uchitomi Y, Yamada N: Association between serious psychological distress and non-participation in cancer screening, and the modifying effect of socioeconomic status: analysis of anonymized data from a national cross-sectional survey in Japan. Cancer. 2018 Feb 1;124(3):555-562. [29076156]
9. Mori M, Fujimori M, Hamano J, Shirado A, Morita T. Which physicians’ behaviors on death pronouncement affect family-perceived physician compassion? A randomized, scripted, video-vignette study. J Pain Symptom Manage. 2018 Feb;55(2):189-197 [28887269]
10. Hayashibara C, Inagaki M, Fujimori M, Higuchi Y, Fujiwara M, Terada S, Okamura H, Uchitomi Y, Yamada N.　Confidence in communicating with patients with cancer mediates the relationship between rehabilitation therapists' autistic-like traits and perceived difficulty in communication. Palliat Support Care. 2018 Jan 21;1-9. [29352834]

2017年

1. Fujiwara M, Inagaki M*, Nakaya N, Fujimori M, Higuchi Y, Hayashibara C, So R, Kakeda K, Kodama M, Uchitomi Y, Yamada N. Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: A cross-sectional study in Japan. Psychiatry Clin Neurosci. 2017 Dec;71(12):813-825. [28875514]
2. Miyaji T, Iioka Y, Kuroda Y, Yamamoto D, Iwase S, Goto Y, Tsuboi M, Odagiri H, Tsubota Y, Kawaguchi T, Sakata N, Basch E, Yamaguchi T: Japanese translation and linguistic validation of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). J Patient Rep Outcomes 2017;1(1):8. [29757296]
3. Wada S, Inoguchi H, Hirayama T, Matsuoka YJ, Uchitomi Y, Ochiai H, Tsukamoto S, Shida D, Kanemitsu Y, Shimizu K*: Yokukansan for the Treatment of Preoperative Anxiety and Postoperative Delirium in Colorectal Cancer Patients: A Retrospective Study. Japanese Jpn J Clin Oncology 2017 Sep 1;47(9): 844-848 [28591818]

2016年

 

旧 健康支援研究部　研究業績

2021年

1. Cheng YS, Tseng PT, Wu MK, Tu YK, Wu YC, Li DJ, Chen TY, Su KP, Stubbs B, Carvalho AF, Lin PY,  Matsuoka YJ, Chen YW, Sun CK*, Shiue YL*. Pharmacologic and hormonal treatments for menopausal sleep disturbances: Anetwork meta-analysis of 43 randomized controlled trials and 32,271 menopausal women. Sleep Medicine Reviews 2021 Mar 11;57:101469 [33836486]
2. Hamazaki K, Matsuoka YJ*, Yamaji T, Sawada N*, Mimura M, Nozaki S, Shikimoto R, Tsugane S. Plasma phospholipid n-3 polyunsaturated fatty acids and major depressive disorder in Japanese elderly: the Japan Public Health Center-based Prospective Study. Scientific Reports 2021 February 17;11(1): 4003 [33597590]
3. Tsuji K*, Matsuoka YJ, Ochi E*: High-intensity interval training in breast cancer survivors: a systematic review. BMC Cancer 2021 Feb 22;21(1):184 [33618699]
4. Nozaki S*, Sawada N*, Matsuoka YJ, Shikimoto R, Mimura M, Tsugane S. Association between dietary fish and PUFA intake in midlife and dementia in later life: the JPHC Saku Mental Health Study. J Alzheimers Dis 2021;79(3):1091-1104 [33386799]
5. Narisawa T, Nishi D, Okubo R, Noguchi H, Yamashita A, Hamazaki K, Matsuoka YJ*. Impact of peritraumatic distress on posttraumatic stress disorder symptoms at 6 months after acute coronary syndrome: a prospective cohort study. European J Psychotraumatology 2021 Jan 13;12(1): 1854511[33505638]
6. Huang KY, Tseng PT, Wu YC, Tu YK, Stubbs B, Su KP, Matsuoka Y, Hsu CW, Lin YW, Chen YW, Lin PY*: Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials. Scientific Reports 2021 Jan 11, 11,452 [33432057]

2020年

1. Tseng PT, Yang CP, Su KP, Chen TY, Wu YC, Tu YK, Lin PY, Stubbs B, Carvalho AF, Matsuoka YJ, Li DJ, Liang CS, Hsum CW, Chen YW, Shiue YL*: The association between melatonin and episodic migraine: a pilot network meta-analysis of randomized controlled trials to compare the prophylactic effects with exogenous melatonin supplementation and pharmacotherapy. J Pineal Res 2020 Sep;69(2):e12663 [32347977]
2. Morishima T*, Tsuchiya Y, Ueda H, Tsuji K, Ochi E: Sitting-induced Endothelial Dysfunction Is Prevented in Endurance-trained Individuals. Medicine & Science in Sports & Exercise 2020 Aug;52(8):1770-1775 [32079922]
3. Hirano T, Motohashi T, Okumura K, Takajo K, Kuroki T, Ichikawa D, Matsuoka Y, Ochi E, Ueno T*: Data validation and verification using blockchain in a clinical trial for breast cancer. J Med Internet Res 2020 June 2;22(6):e18938 [32340974]
4. Matsuoka YJ*, Okubo R, Shimizu Y, Tsuji K, Narisawa T, Sasaki J, Sasai H, Akashi-Tanaka S, Hamaguchi T, Iwasa T, Iwata S, Kato T, Kurotani K, Maruyama D, Mori A, Ogawa A, Sakurai N, Shimazu T, Shimizu C, Tabuchi T, Takahashi M, Takano T, Tatematsu N, Uchitomi Y, Watanabe C, Fukui T. Developing the structure of Japan’s cancer survivorship guidelines using an expert panel and modified Delphi method. J Cancer Survivorship 2020 Jun;14(3):273-283 [31811478]
5. Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, Freeman MP, Maes M, Matsuoka YJ, Belmaker RH, Jacka F, Pariante C, Berk M, Marx W, Su KP*: A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder. J Affective Disorders 2020 March;265:233-238 [32090746]
6. van der Mei WF, Barbano AC*, Ratanatharathorn A, Bryant RA, Delahanty DL, deRoon-Cassini TA, Lai BS, Lowe SR, Matsuoka YJ, Olff M, Qi W, Schnyder U, Seedat S, Kessler RC, Koenen KC, Shalev AY on behalf of the International Consortium to Predict PTSD. Evaluating a Screener to Quantify PTSD Risk Using Emergency Care Information: A Proof of Concept Study. BMC Emergency Medicine 2020 Mar 2;20(1):16 [32122334]
7. Okubo R, Kinoshita T, Katsumata N, Uezono Y, Xiao J, Matsuoka YJ*: Impact of chemotherapy on the association between fear of cancer recurrence and gut microbiota in breast cancer survivors. Brain Behav Immunity 2020 Mar;85:186-191 [30818031]
8. Lowe SR*, Ratanatharathorn A, Lai BS, van der Mei W, Barbano AC, Bryant RA, Delahanty DL, Matsuoka YJ, Olff M, Schnyder U, Laska E, Koenen KC, Shalev AY, Kessler RC on behalf of the ICPP.  Posttraumatic Stress Disorder Symptom Trajectories Within the First Year Following Emergency Department Admissions: Pooled Results from the International Consortium to Predict PTSD. Psychological Medicine 2020 Feb 3;1-11. [32008580]
9. Wu Y, Levis B, Sun Y, Krishnan A, He C, Riehm KE, Rice DB, Azar M, Yan XW, Neupane D, Bhandari PM, Imran M, Chiovitti MJ, Saadat N, Boruff JT, Cuijpers P, Gilbody S, McMillan D, Ioannidis JPA, Kloda LA, Patten SB, Shrier I, Ziegelstein RC, Henry M, Ismail Z, Loiselle CG, Mitchell ND, Tonelli M, Al-Adawi S, Beraldi A, Braeken APBM, Büel-Drabe N, Bunevicius A, Carter G, Chen CK, Cheung G, Clover K, Conroy RM, Cukor D, da Rocha E Silva CE, Dabscheck E, Daray FM, Douven E, Downing MG, Feinstein A, Ferentinos PP, Fischer FH, Flint AJ, Fujimori M, Gallagher P, Gandy M, Goebel S, Grassi L, Härter M, Jenewein J, Jetté N, Julião M, Kim JM, Kim SW, Kjærgaard M, Köhler S, Loosman WL, Löwe B, Martin-Santos R, Massardo L, Matsuoka Y, Mehnert A, Michopoulos I, Misery L, Navines R, O'Donnell ML, Öztürk A, Peceliuniene J, Pintor L, Ponsford JL, Quinn TJ, Reme SE, Reuter K, Rooney AG, Sánchez-González R, Schwarzbold ML, Senturk Cankorur V, Shaaban J, Sharpe L, Sharpe M, Simard S, Singer S, Stafford L, Stone J, Sultan S, Teixeira AL, Tiringer I, Turner A, Walker J, Walterfang M, Wang LJ, White J, Wong DK, Benedetti A, Thombs BD*. Probability of major depression diagnostic classification based on the DCID, CIDI, and MINI diagnostic interviews controlling for hospital anxiety and depression scale – depression subscale scores: An individual participants data meta-analysis of 73 primary studies. J Psychosom Res 2020 Feb;129:109892 [31911325]
10. Shimizu Y, Tsuji K, Ochi E, Arai H, Okubo R, Kuchiba A, Shimazu T, Sakurai N, Narisawa T, Ueno T, Iwata H, Matsuoka YJ*. Study protocol for a nationwide questionnaire survey of physical activity among breast cancer survivors in Japan. BMJ Open 2020;10:e032871 [31964669]

2019年

1. Horigome A, Okubo R, Hamazaki K, Kinoshita T, Katsumata N, Uezono Y, Xiao JZ*, Matsuoka YJ*. Association between blood omega-3 polyunsaturated fatty acids and the gut microbiota among breast cancer survivors. Beneficial Microbes 2019 Oct 14;10(7):751-758. [31965846]
2. Noguchi H, Okubo R, Hamazaki K, Yamashita A, Narisawa T, Matsuoka YJ*: Serum polyunsaturated fatty acids and risk of psychiatric disorder at 6 months after acute coronary syndrome: A prospective cohort study. Prostaglandins Leukot Essent Fatty Acids 2019 Oct;149:18-23. [31421523]
3. Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, Freeman MP, Maes M, Matsuoka YJ, Belmaker RH, Jacka F, Pariante C, Berk M, Marx W, Su KP*: International Society for Nutritional Psychiatric Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder. Psychother Psychosom 2019 Sep 3;88(5):263-273 [31480057]
4. Okubo R, Wada S, Shimizu Y, Tsuji K, Hanai A, Imai K, Uchitomi Y, Fujiwara Y, Tsugane S, Matsuoka YJ*. Expectations of and recommendations for a cancer survivorship guideline in Japan: a literature review of guidelines for cancer survivorship. Jpn J Clinical Oncology 2019 Sep 1;49(9):812-822. [31095338]
5. Tsuji K, Ochi E, Okubo R, Shimizu Y, Kuchiba A, Ueno T, Shimazu T, Kinoshita T, Sakurai N, Matsuoka YJ*. Effect of home-based high intensity intermittent training and behavioral modification using information and communication technology on cardiorespiratory fitness and exercise habits among sedentary breast cancer survivors: habit-B study protocol for a randomized controlled trial. BMJ Open 2019 Aug 22;9(8):e030911 [31444192]
6. Barbano AC*, van der Mei WF, deRoon-Cassini TA, Grauer E, Lowe SR, Matsuoka YJ, O’Donnell M, Olff M, Qi W, Ratanatharathorn A, Schnyder U, Seedat S, Kessler RC, Koenen KC, Shalev AY, On behalf of the International Consortium to Prevent PTSD: Differentiating PTSD from Anxiety and Depression: Lessons from the ICD-11 PTSD Diagnostic Criteria. Depression and Anxiety 2019 Jun;36(6):490-498 [30681235]
7. Watanabe N*, Horikoshi M, Shinmei I, Oe Y, Narisawa T, Kumachi M, Matsuoka Y, Hamazaki K, Furukawa TA. Brief mindfulness-based stress management program for a better mental state in working populations - Happy Nurse Project: a randomized controlled trial. J Affective Disorders 15 May 2019; 251: 186-194 [30927579]
8. Okubo R, Matsuoka YJ*, Sawada N*, Mimura M, Kurotani K, Nozaki S, Shikimoto R, Tsugane S. Diet quality and depression risk in a Japanese population: the Japan Public Health Center (JPHC)-based Prospective Study. Scientific Reports 9,7150, May 9, 2019 [31073185]
9. Wu YC, Tseng PT, Tu YK, Hsu CY, Liang CS, Yeh TC, Chen TY, Chu CS, Matsuoka YJ, Stubbs B, Carvalho AF, Wada S, Lin PY, Chen YW, Su KP*: Association of Delirium Response and Safety of Pharmacological Interventions for the Management and Prevention of Delirium: A Network Meta-analysis. JAMA Psychiatry 2019 May 1;76(5):526-535 [30810723]
10. Satogami K, Tseng PT, Su KP*, Takahashi S, Ukai S, Li DJ, Chen TY, Lin PY, Chen YW, Matsuoka YJ: Relationship between polyunsaturated fatty acid and eating disorders: systematic review and meta-analysis. Prostaglandins Leukot Essent Fatty Acids. 2019 Mar;142: 11-19 [30773209]
11. Nishi D*, Su KP, Usuda K, Chang JPC, Hamazaki K, Ishima T, Sano Y, Ito H, Isaka K, Tachibana Y, Tanigaki S, Suzuki T, Hashimoto K, Matsuoka YJ. Plasma estradiol levels and antidepressant effects of omega 3 fatty acids in pregnant women. Brain Behavior and Immunity 2020 Mar;85: 29-34 [30776476]
12. Shalev A*, Gevonden M, Ratanatharathorn A, Laska E, van der Mei WF, Qi W, Lowe S, Lai BS, Bryant RA, Delahanty D, Matsuoka YJ, Olff M, Schnyder U, Seedat S, deRoon-Cassini TA, Kessler RC, Koenen KC, on behalf of the International Consortium to Predict PTSD. Estimating the risk of PTSD in recent trauma survivors: results of the International Consortium to Predict PTSD (ICPP). World Psychiatry 2019 Feb;18(1): 77-87 [30600620]
13. Okubo R, Koga M, Katsumata N, Odamaki T, Matsuyama S, Oka M, Narita H, Hashimoto N, Kusumi I, Xiao J, Matsuoka YJ*: Effect of Bifidobacterium breve A-1 on anxiety and depressive symptoms in schizophrenia: A proof-of-concept study. J Affective Disorders 2019; 245: 377-385 15 February [30423465]
14. Okubo R, Noguchi H, Narisawa T, Hamazaki K, Sekiguchi M, Kinoshita T, Katsumata N, Xiao JZ, Matsuoka YJ*: Fear of cancer recurrence among breast cancer survivors could be controlled by prudent dietary modification with polyunsaturated fatty acids. J Affective Disorders 245: 1114-1118, 15 February, 2019 [30699854]
15. Nishi D*, Su KP*, Usuda K, Chang JPC, Chiang YJJ, Guu TW, Okazaki E, Hamazaki K, Susukida R, Nakaya N, Sone T, Sano Y, Ito H, Isaka K, Tachibana Y, Tanigaki S, Suzuki T, Hashimoto K, Hamazaki T, Matsuoka YJ: The efficacy of omega 3 fatty acids for depressive symptoms among pregnant women in Japan and Taiwan: A randomized, double-blind, placebo-controlled trial (SYNCHRO; NCT01948596). Psychother Psychosom 2019;88(2): 122-124. [30540990]
16. Yoshikawa E, Nishi D*, Kashimura M, Matsuoka YJ: Role of resilience for the association between trait hostility and depressive symptoms in Japanese company workers. Curr Psychol 07 February 2019 [https://doi.org/10.1007/s12144-019-0166-y]
17. Barbano AC*, van der Mei WF, Bryant RA, Delahany DL, deRoon-Cassini TA, Matsuoka YJ, Olff M, Qi W, Ratanatharathorn A, Schnyder U, Seedat S, Kessler RC, Koenen KC and Shalev AY: Clinical implications of the proposed ICD-11 PTSD criteria. Psychological Medicine. 2019 Feb;49(3): 483-490 [29754591]

2018年

1. Kurosawa K, Terao T*, Kanehisa M, Shiotsuki I, Ishii N, Takenaka R, Sakamoto T, Matsukawa T, Ando S, Nishida A, Matsuoka Y: Naturally absorbed polyunsaturated fatty acids, lithium, and suicide-related behaviors: a case-controlled study. J Affective Disorders 2018 Dec1 ; 241:200-205 [30130685]
2. Matsumura K*, Noguchi H, Rolfe P, Yamakoshi T, Matsuoka Y: Differential effect of two mental stress tasks on arterial stiffness. Japanese Psychological Research 23 October 2019;61(4):249-261 [http://doi.org/10.1111/jpr.12235]
3. Su KP, Tseng PT, Lin PY, Okubo R, Chen TY, Chen YW, Matsuoka YJ*: Association of Use of Omega-3 Polyunsaturated Fatty Acids With Changes in Severity of Anxiety Symptoms. A Systematic Review and Meta-analysis. JAMA Network Open 2018 Sep 7;1(5):e182327. [30646157]
4. Watanabe N*, Matsuoka Y, Kumachi M, Hamazaki K, Horikoshi M, Furukawa TA: Omega-3 fatty acids for a better mental state in working populations - Happy Nurse Project: a 52-week randomized controlled trial. J Psychiatric Research 2018; 102: 72-80 [29627596]
5. Wei Qi*, Ratanatharathorn A, Gevonden M, Bryant R, Delahanty D, Matsuoka Y, Olff M, deRoon-Cassini T, Schnyder U, Seedat S, Laska E, Kessler R, Koenen K, Shalev A on behalf of the ICPP: Application of Data Pooling to Longitudinal Studies of Early PTSD: The International Consortium to Predict PTSD (ICPP) Project. Eur J Psychotraumatol 2018 Jun 14;9(1):1476442 [29938009]
6. Okubo R, Chen C, Sekiguchi M, Hamazaki K, Matsuoka YJ*: Mechanisms underlying the effects of n-3 polyunsaturated fatty acids on fear memory processing and their hypothetical effects on fear of cancer recurrence in cancer survivors. Prostaglandins Leukot Essent Fatty Acids 2018 Apr;131:14-23 [29628046]
7. Furuno T, Nakagawa M, Hino K, Shirakawa O, Yamada T, Kawashima Y, Matsuoka Y, Shirakawa O, Ishizuka N, Yonemoto N, Kawanishi C, Hirayasu Y: Effectiveness of assertive case management on repeat self-harm in patients admitted for suicide attempt: findings from ACTION-J study. J Affective Disorders 2018 Jan 1;225:460-465. [28863298]

2017年

1. Noguchi H, Nishi D, Matsumura K, Hamazaki K, Hamazaki T, Matsuoka Y: Limited effect of omega-3 fatty acids on the quality of life in survivors of traumatic injury: A randomized, placebo-controlled trial. Prostaglandins Leukot Essent Fatty Acids. 2017 Dec;127:1-5. [29156152]
2. Matsumura K, Noguchi H, Nishi D, Hamazaki K, Hamazaki T, Matsuoka YJ: Effects of omega-3 polyunsaturated fatty acids on psychophysiological symptoms of post-traumatic stress disorder in accident survivors: a randomized, double-blind, placebo-controlled trial. J Affective Disorders 2017 December 15;224: 27-31 [27287561]
3. Okubo R, Inoue T, Hashimoto N, Suzukawa A, Tanabe H, Oka M, Narita H, Ito K, Kako Y, Kusumi I: The mediator effect of personality traits on the relationship between childhood abuse and depressive symptoms in schizophrenia. Psychiatry Res. 2017 Nov;257:126-131 [28755602]
4. Matsuoka YJ, Sawada N, Mimura M, Shikimoto R, Nozaki S, Hamazaki K, Uchitomi Y, Tsugane S: Dietary fish, n-3 polyunsaturated fatty acid consumption, and depression risk in Japan: a population-based prospective cohort study. Transl Psychiatry 2017 Sep 26;7(9):e1242 [28949340]
5. Nagamine M, Noguchi H, Takahashi N, Kim Y, Matsuoka Y: Effect of cortisol diurnal rhythm on emotional memory in healthy young adults. Scientific Reports 2017 Aug 31;7(1): 10158 [28860606]
6. Yamashita A, Noguchi H, Hamazaki K, Sato Y, Narisawa T, Kawashima Y, Usuki M, Nishi D, Yoshimasu H, Horikawa N, Matsuoka YJ: Serum polyunsaturated fatty acids and risk of psychiatric disorder after acute coronary syndrome: a prospective cohort study. J Affective Disorders August 2017 Aug 15;218: 306-312. [31421523]
7. Nishi D, Su KP, Usuda K, Chang PC, Chiang YJ, Guu TW, Hamazaki K, Nakaya N, Sone T, Hashimoto K, Hamazaki T, Matsuoka YJ: Differences between Japan and Taiwan in the treatment of pregnant women with depressive symptoms by omega-3 fatty acids: an open label pilot study. Nutritional Neuroscience 2017 Jul 28:1-9 [28752805]

2016年

1. Kawashima Y, Nishi D, Noguchi H, Usuki M, Yamashita A, Koido Y, Okubo Y, Matsuoka Y*: Post-traumatic Stress Symptoms and Burnout Among Medical Rescue Workers 4 Years after the Great East Japan Earthquake: A Longitudinal Study. Disaster Medicine and Public Health Preparedness 2016 Dec;10(6): 848-853 [27188495]
2. Matsuoka YJ*, Hamazaki K, Nishi D, Hamazaki T: Change in blood levels of eicosapentaenoic acid and posttraumatic stress symptom: A secondary analysis of data from a placebo-controlled trial of omega-3 supplements J Affective Disorders 2016 Dec;10(6): 848-853 [27552592]
3. Tanisho Y, Shigemura J, Kubota K, Tanigawa T, Bromet EJ, Takahashi S, Matsuoka Y, Nishi D, Nagamine M, Harada N, Tanichi M, Takahashi Y, Shimizu K, Nomura S, Yoshino A, Fukushima NEWS Project Collaborators: The longitudinal mental health impact of Fukushima nuclear disaster exposures and public criticism among power plant workers: the Fukushima NEWS Project study. Psychol Med 2016 Nov;46(15):3117-3125. [27534897]
4. Yoshikawa E, Nishi D*, Matsuoka YJ: Association between frequency of fried food consumption and resilience to depression in Japanese company workers: A cross-sectional study. Lipids Health Dis. 2016 Sep 15;15(1):156 [27633655]
5. Nishi D, Su K-P, Usuda K, Chiang Y-J, Guu T-W, Hamazaki K, Nakaya N, Sone T, Sano Y, Tachibana Y, Ito H, Isaka K, Hashimoto K, Hamazaki T, Matsuoka YJ: The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial. BMC Psychiatry 2016 Sep 15;16(1):321. [27630014]
6. Nishi D, Kawashima Y, Noguchi H, Usuki M, Yamashita A, Koido Y, Matsuoka YJ*: Resilience, posttraumatic growth and work engagement among health care professionals after the Great East Japan Earthquake: A 4-year prospective follow-up study. J Occupational Health. 2016 Jul 22;58(4):347-53 [27265533]
7. Yoshikawa E, Nishi D*, Matsuoka YJ: Association between regular physical exercise and depressive symptoms mediated through social support and resilience in Japanese company workers: A cross-sectional study. BMC Public Health 2016 Jul 22;58(4): 347-53 [27405459]
8. Usuda K, Nishi D, Makino M, Tachimori H, Matsuoka Y, Sano Y, Konishi T, Takeshima T: Prevalence and related factors of common mental disorders during pregnancy in Japan: a cross-sectional study. Biopsychosocial Medicine 2016 Jul 12;16: 553 [27213012]